Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Tokyo  >  Chugai Pharmaceutical Co Ltd    4519   JP3519400000

CHUGAI PHARMACEUTICAL CO LTD (4519)
Mes dernières consult.
Most popular
  Report  
 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ( JPY)
Sales 2018 557 B
EBIT 2018 -
Net income 2018 84 156 M
Finance 2018 211 B
Yield 2018 1,27%
Sales 2019 611 B
EBIT 2019 -
Net income 2019 102 B
Finance 2019 236 B
Yield 2019 1,54%
P/E ratio 2018 34,86
P/E ratio 2019 28,29
EV / Sales2018 5,09x
EV / Sales2019 4,59x
Capitalization 3 045 B
More Financials
Company
Chugai Pharmaceutical Co., Ltd. engages in the manufacture, sale, import, and export of pharmaceutical.Its products include oncology drugs, bone and joint drugs, renal diseases drugs, and therapeutic antibodies.The company was founded by Juzo Ueno on March 10, 1925 and is headquartered in Tokyo,... 
Sector
Pharmaceuticals
Calendar
03/22Shareholder meeting
More about the company
Surperformance© ratings of Chugai Pharmaceutical Co L
Trading Rating : Investor Rating :
More Ratings
Latest news on CHUGAI PHARMACEUTICAL CO L
02/08CHUGAI PHARMACEUTICAL : Investigators at Chugai Pharmaceutical Zero in on Liver ..
AQ
02/01CHUGAI PHARMACEUTICAL : Notice Concerning the Difference Regarding Individual Fi..
PU
02/01CHUGAI PHARMACEUTICAL : Further Improving Access to Therapies for Non-Small Cell..
PU
01/30CHUGAI PHARMACEUTICAL : HEMLIBRA Gains Positive CHMP Opinion in Hemophilia A wit..
AQ
01/29CHUGAI PHARMACEUTICAL : HEMLIBRA® Gains Positive CHMP Opinion in Hemophilia A wi..
BU
01/24CHUGAI PHARMACEUTICAL : Obtains Approval of Humanized Anti-PD-L1 Monoclonal Anti..
AQ
01/09CHUGAI PHARMACEUTICAL : Filing of Patent Infringement Lawsuit Concerning Rituxan..
PU
01/05CHUGAI PHARMACEUTICAL : Notice Concerning Execution of Asset Transfer of 13 Long..
PU
2017CHUGAI PHARMACEUTICAL : Pharma to inject $220m into Singapore bio drug lab
AQ
2017CHUGAI PHARMACEUTICAL : The Launch of Chugai's New Corporate Advertisement - 'Fo..
AQ
More news
Sector news : Pharmaceuticals - NEC
01:46pPUMA BIOTECHNOLOGY : EU panel recommends against nod for Puma Biotech's breast c..
RE
12:30pSANOFI : Says U.S. Waiting Period for Bioverativ Has Expired
DJ
11:10aSHIRE : FDA to Conduct Priority Review of Shire Genetic-Disorder Drug
DJ
08:48aNOVARTIS : Greek Parliament Approves Bribery and Price Fix Inquiry on Novartis -..
DJ
02/22NOVARTIS : Greek Parliament Investigates Politicians in Novartis Bribery Probe
DJ
More sector news : Pharmaceuticals - NEC
Latest Tweets
02/21NeoRecormon (epoetin beta; Roche/Chugai) Drug Analysis Report 2018 -  
02/21NeoRecormon (epoetin beta; Roche/Chugai) Drug Analysis Report 2018 - : DUBLIN.. 
02/20Mircera (methoxy polyethylene glycol-epoetin beta; Roche/Vifor/Chugai) Drug A.. 
02/152018 Tecentriq (atezolizumab; Roche/Chugai) Drug Analysis: A Fully Humanized .. 
02/152018 Tecentriq (atezolizumab; Roche/Chugai) Drug Analysis: A Fully Humanized .. 
More tweets
Qtime:19
News from SeekingAlpha
02/02Chugai Pharmaceutical Co., Ltd. ADR 2017 Q4 - Results - Earnings Call Slides 
2017Chugai Pharmaceutical Co., Ltd. ADR 2017 Q3 - Results - Earnings Call Slides 
2017ROCHE : Buying The Dip 
2017Chugai Pharmaceutical reports Q3 results 
2017Chugai Pharmaceutical reports 1H results 
Chart CHUGAI PHARMACEUTICAL CO L
Duration : Period :
Chugai Pharmaceutical Co L Technical Analysis Chart | 4519 | JP3519400000 | 4-Traders
Technical analysis trends CHUGAI PHARMACEUTICAL CO L
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 5 782  JPY
Spread / Average Target 6,3%
EPS Revisions
Managers
NameTitle
Osamu Nagayama Chairman & Chief Executive Officer
Tatsuro Kosaka President, COO & Representative Director
Yoshio Itaya Chief Financial Officer & Director
Keiji Kono Executive Officer & Manager-IT Supervisory Section
Motoo Ueno Vice Chairman & Head-Audit
Sector and Competitors
1st jan.Capitalization (M$)
CHUGAI PHARMACEUTICAL CO LTD-5.72%28 437
JOHNSON & JOHNSON-7.02%349 006
NOVARTIS-2.94%224 221
PFIZER-1.27%213 155
ROCHE HOLDING LTD.-9.41%207 327
MERCK AND COMPANY-3.06%148 618